Pulmonary edema

Pulmonary edema
Specialty	Pulmonology, cardiology, medical emergency

Pulmonary edema (American English), or oedema (British English; both words from the Greek οἴδημα), is fluid accumulation in the lungs. It leads to impaired gas exchange and may cause respiratory failure. It is due to either failure of the heart to remove fluid from the lung circulation ("cardiogenic pulmonary edema") or a direct injury to the lung parenchyma ("noncardiogenic pulmonary edema"). Treatment depends on the cause, but focuses on maximizing respiratory function and removing the cause.

Signs and symptoms

Symptoms of pulmonary edema include difficulty breathing, coughing up blood, excessive sweating, anxiety, and pale skin. A classic sign of pulmonary edema is the production of pink frothy sputum. If left untreated, it can lead to coma and even death, in general, due to its main complication of hypoxia. If pulmonary edema has been developing gradually, symptoms of fluid overload may be elicited. These include nocturia (frequent urination at night), ankle edema (swelling of the legs, in general, of the "pitting" variety, wherein the skin is slow to return to normal when pressed upon), orthopnea (inability to lie down flat due to breathlessness), and paroxysmal nocturnal dyspnea (episodes of severe sudden breathlessness at night).

Diagnosis

In general, pulmonary edema is suspected due to findings in the medical history, such as previous cardiovascular disease, and physical examination: End-inspiratory crackles (sounds heard at the end of a deep breath) on auscultation are characteristic for pulmonary edema. The presence of a third heart sound (S3) is predictive of cardiogenic pulmonary edema..

In general, blood tests are performed for electrolytes (sodium, potassium) and markers of renal function (creatinine, urea). Liver enzymes, inflammatory markers (usually C-reactive protein) and a complete blood count as well as coagulation studies (PT, aPTT) are typically requested. B-type natriuretic peptide (BNP) is available in many hospitals, sometimes even as a point-of-care test. Low levels of BNP (<100 pg/ml) make a cardiac cause very unlikely.

The diagnosis is confirmed on X-ray of the lungs, which shows increased fluid in the alveolar walls. Kerley B lines, increased vascular filling, pleural effusions, upper lobe diversion (increased blood flow to the higher parts of the lung) may be indicative of cardiogenic pulmonary edema, whereas patchy alveolar infiltrates with air bronchograms are more indicative of noncardiogenic edema

Low oxygen saturation and disturbed arterial blood gas readings may strengthen the diagnosis and provide grounds for various forms of treatment. If urgent echocardiography is available, this may strengthen the diagnosis, as well as identify valvular heart disease. In rare occasions, insertion of a Swan-Ganz catheter may be required to distinguish between the two main forms of pulmonary edema.

Causes

Pulmonary edema is either due to direct damage to the tissue or a result of inadequate functioning of the heart or circulatory system.

When directly or indirectly caused by increased pulmonary blood pressure, pulmonary edema may appear when this pressure increases from the normal 15 mmHg to above 25 mmHg.

Cardiogenic

• Congestive heart failure
• Severe heart attack with left ventricular failure
• Severe arrhythmias (tachycardia/fast heartbeat or bradycardia/slow heartbeat)
• Hypertensive crisis
• Pericardial effusion with tamponade
• Fluid overload, e.g., from kidney failure or intravenous therapy

Non-cardiogenic

May occur after upper airway obstruction, intravenous fluid overload, neurogenic causes (seizures, head trauma, strangulation, electrocution). Can also be seen with ARDS (adult respiratory distress syndrome):

Alveolar

• Inhalation of toxic gases
• Pulmonary contusion, i.e., high-energy trauma
• Aspiration, e.g., gastric fluid or in case of drowning
• Reexpansion, i.e. post [[large volume thoracentesis, resolution of pneumothorax, post decortication, removal of endobronchial obstruction
• Reperfusion injury, i.e. postpulmonary thromboendartectomy or lung transplantation
• Immersion pulmonary edema
• Multiple blood transfusions
• Severe infection

Other/unknown

• Multitrauma, e.g., severe car accident
• Neurogenic, e.g., subarachnoid hemorrhage
• Certain types of medication, illicit drug use
• Upper airway obstruction, i.e. negative pressure pulmonary edema
• Arteriovenous malformation
• Hantavirus pulmonary syndrome
• Ascent to high altitude occasionally causes high altitude pulmonary edema (HAPE)

Management

Focus is initially on maintaining adequate oxygenation. The patient is given high-flow oxygen, noninvasive ventilation (either continuous positive airway pressure (CPAP) or variable positive airway pressure (VPAP)) or mechanical ventilation and PEEP in very severe cases.

When circulatory causes have led to pulmonary edema, treatment with intravenous nitrates (glyceryl trinitrate), and loop diuretics, such as furosemide or bumetanide, is the mainstay of therapy. These improve both preload and afterload, and aid in improving cardiac function.

Sildenafil is used as a preventative treatment for altitude-induced pulmonary edema, although the mechanism of action is not known. While this effect has only recently been discovered, sildenafil is already becoming an accepted treatment for this condition, in particular in situations where the standard treatment of rapid descent has been delayed for some reason.

See also

• High Altitude Pulmonary Edema
• Flash pulmonary edema
• Swimming Induced Pulmonary Edema

External links

• HeartFailureMatters.org Animation showing How Heart Failure causes Fluid Accumulation - Created by the European Heart Failure Association